Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Abrocitinib may effectively treat Lichen Planopilaris.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Inhibiting plant sterols reduces grapevine pathogen reproduction.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

A man developed an allergic skin reaction after using brimonidine for rosacea.

A 9-year-old girl with a healthy immune system was successfully treated for a severe fungal scalp infection caused by Microsporum audouinii.

Bimekizumab effectively treated a man's chronic beard hair loss.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Spironolactone is an effective and safe treatment for acne in adult women.

Co-trimoxazole may help treat autoimmune diseases.

A man developed an allergic skin reaction to a rosacea treatment and improved after stopping the medication and receiving allergy-specific care.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Clofazimine effectively treated ashy dermatosis in a patient.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Deltsid 7.5 is the most effective treatment for bovine psoroptosis.